Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7076
Pacific Biosciences
PACB
$357M
| $819K | ﹤0.01% |
31,558
-273,698
| -90% | -$4.65M |
|
7077
CALL
iShares Mortgage Real Estate ETF
REM
$546M
| $819K | ﹤0.01% |
25,700
-91,400
| -78% | -$2.64M |
|
7078
Viemed Healthcare
VMD
$350M
| $819K | ﹤0.01% |
105,638
+88,017
| +500% | +$774K |
|
|
ALBO
7079
CALL
DELISTED
Albireo Pharma Inc
ALBO
| $818K | ﹤0.01% |
21,800
-4,800
| -18% | -$175K |
|
|
GNOG
7080
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
| $818K | ﹤0.01% |
41,521
-47,649
| -53% | -$805K |
|
|
AEGN
7081
DELISTED
Aegion Corp
AEGN
| $818K | ﹤0.01% |
43,067
+25,684
| +148% | +$430K |
|
|
OSG
7082
CALL
Octave Specialty Group
OSG
$221M
| $817K | ﹤0.01% |
53,100
+4,100
| +8% | +$60.4K |
|
7083
CALL
Primerica
PRI
$9.65B
| $817K | ﹤0.01% |
6,100
-5,600
| -48% | -$704K |
|
7084
PUT
Vuzix
VUZI
$262M
| $817K | ﹤0.01% |
90,000
+10,100
| +13% | +$50.4K |
|
|
FLG
7085
PUT
Flagstar Bank National Association
FLG
$5.92B
| $816K | ﹤0.01% |
25,767
-2,666
| -9% | -$73.5K |
|
|
NSTG
7086
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
| $816K | ﹤0.01% |
12,200
+4,500
| +58% | +$226K |
|
7087
CALL
Gildan
GIL
$10.5B
| $815K | ﹤0.01% |
29,100
-5,400
| -16% | -$133K |
|
7088
CGI
GIB
$15.2B
| $814K | ﹤0.01% |
10,264
-18,371
| -64% | -$1.31M |
|
|
VTLE
7089
PUT
DELISTED
Vital Energy
VTLE
| $814K | ﹤0.01% |
41,300
+20,400
| +98% | +$263K |
|
7090
CALL
SPX Corp
SPXC
$10.9B
| $813K | ﹤0.01% |
14,900
-1,900
| -11% | -$95.4K |
|
7091
Trimble
TRMB
$13.4B
| $813K | ﹤0.01% |
12,169
-396,605
| -97% | -$22.8M |
|
|
ARR
7092
PUT
Armour Residential REIT
ARR
$2.37B
| $812K | ﹤0.01% |
15,060
-2,620
| -15% | -$135K |
|
7093
Astec Industries
ASTE
$997M
| $812K | ﹤0.01% |
14,014
+7,549
| +117% | +$430K |
|
7094
PUT
Bruker
BRKR
$8.79B
| $812K | ﹤0.01% |
15,000
+8,000
| +114% | +$384K |
|
7095
Avis
CAR
$4.87B
| $812K | ﹤0.01% |
+21,777
| New | +$765K |
|
7096
CEVA Inc
CEVA
$937M
| $812K | ﹤0.01% |
17,841
-60,253
| -77% | -$2.47M |
|
7097
VanEck Uranium + Nuclear Energy ETF
NLR
$4.18B
| $812K | ﹤0.01% |
16,507
-1,466
| -8% | -$70K |
|
7098
PUT
Icahn Enterprises
IEP
$5.27B
| $811K | ﹤0.01% |
16,000
+9,000
| +129% | +$458K |
|
|
FRAK
7099
DELISTED
VanEck Vectors Unconventional Oil & Gas ETF
FRAK
| $811K | ﹤0.01% |
10,608
+2,275
| +27% | +$151K |
|
7100
PUT
ProShares UltraShort Bloomberg Natural Gas
KOLD
$105M
| $810K | ﹤0.01% |
1,710
+380
| +29% | +$150K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.